Published in Law and Health Weekly, August 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Ortho-McNeil, Inc.
Report 1: Ortho-McNeil, Inc. announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET(R) (tramadol/acetaminophen).
As part of the settlement, Par/Kali acknowledged that the reissue patent for ULTRACET(R) is valid and enforceable, and that they infringed it by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.